Invex Therapeutics Ltd

ASX:IXC Rapporto sulle azioni

Cap. di mercato: AU$5.3m

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Invex Therapeutics Gestione

Gestione criteri di controllo 1/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOno data
Proprietà del CEOn/a
Durata media del managementNessun dato
Durata media del Consiglio di amministrazione3.9yrs

Aggiornamenti recenti sulla gestione

Recent updates

We're Hopeful That Invex Therapeutics (ASX:IXC) Will Use Its Cash Wisely

Jun 09
We're Hopeful That Invex Therapeutics (ASX:IXC) Will Use Its Cash Wisely

We're Hopeful That Invex Therapeutics (ASX:IXC) Will Use Its Cash Wisely

Jan 11
We're Hopeful That Invex Therapeutics (ASX:IXC) Will Use Its Cash Wisely

We Think Invex Therapeutics (ASX:IXC) Can Afford To Drive Business Growth

Aug 24
We Think Invex Therapeutics (ASX:IXC) Can Afford To Drive Business Growth

Companies Like Invex Therapeutics (ASX:IXC) Are In A Position To Invest In Growth

May 10
Companies Like Invex Therapeutics (ASX:IXC) Are In A Position To Invest In Growth

Companies Like Invex Therapeutics (ASX:IXC) Can Afford To Invest In Growth

Jan 25
Companies Like Invex Therapeutics (ASX:IXC) Can Afford To Invest In Growth

We're Interested To See How Invex Therapeutics (ASX:IXC) Uses Its Cash Hoard To Grow

Sep 27
We're Interested To See How Invex Therapeutics (ASX:IXC) Uses Its Cash Hoard To Grow

We're Hopeful That Invex Therapeutics (ASX:IXC) Will Use Its Cash Wisely

Mar 31
We're Hopeful That Invex Therapeutics (ASX:IXC) Will Use Its Cash Wisely

Should You Review Recent Insider Transactions At Invex Therapeutics Ltd (ASX:IXC)?

Feb 06
Should You Review Recent Insider Transactions At Invex Therapeutics Ltd (ASX:IXC)?

We're Hopeful That Invex Therapeutics (ASX:IXC) Will Use Its Cash Wisely

Dec 15
We're Hopeful That Invex Therapeutics (ASX:IXC) Will Use Its Cash Wisely

AMMINISTRATORE DELEGATO

Invex Therapeutics non ha un CEO, o non abbiamo dati su di loro.


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Thomas Duthy
Executive Director3.9yrsAU$357.23k0.38%
A$ 20.0k
David McAuliffe
Non-Executive Chairman5.5yrsAU$57.24k4.46%
A$ 234.5k
David Wheeler
Non-Executive Directorless than a yearAU$36.17kNessun dato

3.9yrs

Durata media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di IXC sono considerati esperti (durata media dell'incarico 3.8 anni).